`
`Receipt date: 07/27/2022
`
`L7/870,172 ~ GAU: 3745
`
`PTO/SB/08a (02-18)
`Doc code: IDS
`Approvedfor use through 11/30/2020. OMB 0651-0031
`.
`.
`.
`sg.
`U.S. Patent and Trademark Office: U.S. DEPARTMENT OF COMMERCE
`Doc description: Information Disclosure Statement (IDS) Filed
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Number
`
`Filing Date
`
`
`
`First Named Inventor
`
`
`
`
`
`Examiner Name Attorney Docket Number
`
`
`| 7870171
`
`omarSSCS
`
`
`
`
`| P04000USC8
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Art Unit
`
`
`
`U.S.PATENTS [Remove|
`
`
`Examiner] Cite
`Initial*
`No
`
`Patent Number
`
`Kind
`Code’ Issue Date
`
`Name of Patentee or Applicant
`of cited Document
`
`902418
`
`933-03-21
`
`Pilgrim Ernest C
`
`Pages,Columns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`
`
`
`944-08-22
`
`Aguiar Clovis De Paiva
`
`
`
`953-08-18
`
`eyer Ferdinand M
`
`953-12-29
`
`Abresch Carel F
`
`
`
`
`
`
`
`
`
`
`
`957-04-23
`
`Doble Warren
`
`958-10-14
`
`augher Robert E
`
`959-07-28
`
`hapmanHarold Eric
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`Receipt date:
`07/27/2022
`L7/870,171 - GAU: 3745
`
`Application Number
`17870171
`
`
`Filing Date
`2022-07-21
`
`
`
` Attorney Docket Number
`
`
`eeeeee
`[>CadCadCadCadCadCadCadCadaa=o©cocoaaawoO©©=To}oOoD==aoOeowowonaoaoeaoNOQanaoQoaOwoa©©oNa~oeoSoOaoe=oSa=NSwoNOa&o~=coNOoOOQ=>cooO
`
`
`
`INFORMATION DISCLOSURE
` First Named Inventor|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`
`
`Art Unit |
`
`Examiner Name
`
` | P04000USC8 _eS 36es2oma=oB3oOwo3>
`
`960-04-19
`
`ccray Alan A
`
`Donaldson John Shearman
`
`960-05-03
`
`963-03-12
`
`967-02-14
`
`969-07-15
`
`mil G. Marcmann
`
`970-05-05
`
`homas R. Smith
`
`974-05-28
`
`urwitz
`
`975-01-21
`
`975-09-09
`
`Renard et al.
`
`976-12-07
`
`978-09-19
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`| PO4000USC8
`
` Attorney Docket Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
`Art Unit
`
`Examiner Name
`
`
`
`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`17870171
`Application Number
`
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`a)))CJCJCJaSSoSco=oA===o=woco~=wN=o&coaNa©NoSo~lNo=NONO=coao&ooSaNo=&=aNaoS
`
`Nai
`
`26
`
`27
`
`28
`
`264606
`
`29
`
`267667
`
`30
`
`335192
`
`EFS Web 2.1.18
`
`SSSSSS 3=
`
`978-12-12
`
`979-01-23
`
`992-05-12
`
`998-07-07
`
`999-03-30
`
`PO04-11-16
`
`P005-05-31
`
`P007-09-04
`
`p007-09-11
`
`P008-02-26
`
`= a53 =QoD a
`
`-09-
`
`No —_—
`
`akahashi et al
`
`wang et al.
`
`arvik
`
`arvik
`
`ulfman etal.
`
`arvik etal.
`
`joudeetal.
`
`eren etal.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`
`
`Receipt date: 07/27/2022 L7/870,172 ~ GAU: 3745
`
`Application Number
`17870171
`
`
`
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT |.
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`Attorney Docket Number
`
`| P04000USC8
`
`
`
`
`
`| 657324 |P010-02-02
`estlundetal.
`
`| 820205 |P010-10-26
`akakusagietal.
`
`>|B376707 |P013-02-19 cBrideetal.
`
`
`>|9089634 |P015-07-28 Schumacheretal.
`
`If you wish to add additional U.S. Patent citation information please click the Add button.
`
`U.S.PATENT APPLICATION PUBLICATIONS
`
`
`Examiner] Kind|Publication,. Publication Nameof Patentee or Applicant Pages,Columns,Lines where
`
`
`
`
`:
`aie
`Cite No
`Relevant Passages or Relevant
`
`of cited Document
`Initial
`Number
`Code’) Date
`.
`Figures Appear
`
`
`
`
`i?0020107506
`
`
`
`P002-08-08
`
`cGuckinJamesFJR.etal.
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`| P04000USC8
`
`P0020111663
`
`A=
`
`DO02-08-15
`
`Dahl et al.
`
`Y0020151761
`
`DO02-02-15
`
`Steven F. Bolling
`
`P0020169413
`
`DO02-05-21
`
`ad Keren
`
`P0030018380
`
`=
`
`DO03-01-23
`
`Y0030023201
`
`=
`
`D003-01-30
`
`P0030100819
`
`—_
`
`DO03-05-29
`
`raig Charles H. et al.
`
`ewman Richard W.et al.
`
`Aboul-Hosnetal.
`
`P0030135086
`
`=
`
`DO03-07-17
`
`haw et al.
`
`P0030187322
`
`=
`
`DO03-10-02
`
`S
`
`~
`
`Aboul-Hosnetal.
`
`Aboul-Hosnetal.
`
`P0030205233
`
`Al
`
`DOO3-11-06
`
`P0030208097
`
`A=
`
`DOO3-11-06
`
`P0030231959
`
`A=
`
`DO03-12-18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`~~!on>who
`
`—_
`
`No
`
`EFS Web 2.1.18
`
`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`
`Application Number 17870171
`
`
`
`Filing Date 2022-07-21
`
` Attorney Docket Number
`
`
`
`Art Unit |
`
`Examiner Name
`
`
`
`
`
`

`

`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`
`Application Number 17870171
`
`
`
`Filing Date 2022-07-21
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`
`
`Art Unit |
`
`Examiner Name
`
` Attorney Docket Number
`
`| P04000USC8
`
`
`
`—_
`
`oa
`
`—_ ~!
`
`NoSo
`
`ho
`
`BNOBNO——wwBo=>ww
`
`
`
`P0040019251
`
`A=
`
`P004-01-29
`
`iole etal.
`
`P0040044266
`
`A=
`
`|— eee
`
`P0040101406
`
`Al
`
`|—
`
`P0040113502
`
`=
`
`P004-06-17
`
`P0040236173
`
`=
`
`|— | “
`
`
`
`i
`
`P0050049696
`
`—
`
`P0050085683
`
`=
`
`| eee
`
`
`Bolling Steven F. et al.
`
`P005-04-21
`
`P0050090883
`
`=
`
`P005-04-28
`
`estlund et al.
`
`P0050095124
`
`Al
`
`P005-05-05
`
`V0050113631
`
`A=
`
`P005-05-26
`
`P0050135942
`
`A=
`
`P005-06-23
`
`Amold Kim M. etal.
`
`ood Houston G.- et al.
`
`Bolling Steven F. et al.
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`
`
`

`

`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`
`Application Number 17870171
`Filing Date 2022-07-21
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
` Attorney Docket Number
`
`
`
`
`
`Art Unit |
`
`Examiner Name
`
`P0050137680
`
`A=
`
`DO05-06-23
`
`Ortiz et al.
`
`
`
`Aboul-Hosnetal.
`
`P0050165269
`
`AS
`
`PO05-07-28
`
`P0050250975
`
`Al
`
`|a | /
`
`P0060018943
`
`=
`
`|~ “
`
`P0060058869
`
`=
`
`|-
`
`P0060063965
`
`—_
`
`P0060089521
`
`=
`
`PO06-03-23
`
`Aboul-Hosnetal.
`
`
`| pe
`
`V0060155158
`
`=
`
`|—
`
`P0060264695
`
`Al
`
`|- | “
`
`P0060270894
`
`A=
`
`|- | ~
`
`P0070100314
`
`A=
`
`|
`
`
`
`| P04000USC8
`
`
`
`NoaowwNoNoNo
`
`No~]
`
`Noco
`
`wSo
`
`ww =
`
`wNo
`
`
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`17870171
`Application Number
`
`| PO4000USC8
`
` Attorney Docket Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
`Art Unit
`
`Examiner Name
`
`
`
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`w~]>>awwwanoSoSaoa
`
`wco
`
`ww©
`
`a =
`
`tsBo
`
`fs.w
`
`
`
`P0070156006
`
`A=
`
`DOO?-07-05 ee
`
`P0070203442
`
`A=
`
`P007-08-30
`
`Bechert etal.
`
`P0070208298
`
`Al
`
`PO07-09-06
`
`
`
`Ainsworthetal.
`
`P0070233270
`
`=
`
`POO7-10-04
`
`eberet al.
`
`P0070282417
`
`=
`
`POO7-12-06
`
`joustonetal.
`
`P0080004645
`
`—_
`
`P008-01-03
`
`o etal.
`
`P0080004690
`
`=
`
`P008-01-03
`
`Robaina
`
`P0080031953
`
`=
`
`P008-02-07
`
`
`
`akakusagietal.
`
`P0080 103442
`
`>1
`
`P008-05-01
`
`esten et al.
`
`P0080103516
`
`A=
`
`P008-05-01
`
`ulfman etal.
`
`V0080103591
`
`A=
`
`P008-05-01
`
`me
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`| PO4000USC8
`
` Attorney Docket Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
`Art Unit
`
`Examiner Name
`
`
`
`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`17870171
`Application Number
`
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`oarsononon>aaooa=~ao
`
`co
`
`a©
`
`anSo
`
`aoNo
`
`onw
`
`
`
`P0080114339
`
`A=
`
`Nad
`
`o2& on —_= on
`
`Bride et al.
`
`P0080119943
`
`A=
`
`DO08-05-22
`
`P0080132748
`
`Al
`
`DO08-06-05
`
`P0080167679
`
`=
`
`DO008-07-10
`
`P0080275290
`
`=
`
`DOO8-11-06
`
`P0080306327
`
`—_
`
`DO08-12-11
`
`P0090018567
`
`=
`
`DO09-01-15
`
`P0090023975
`
`=
`
`DO09-01-22
`
`P0090024085
`
`Al
`
`DO09-01-22
`
`P0090060743
`
`A=
`
`DO09-03-05
`
`P0090062597
`
`A=
`
`DO09-03-05
`
`Armstrong etal.
`
`GGSG=.=.=.===oooooo===oOoOoO
`
`iole et al.
`
`scuderoetal.
`
`arseille et al.
`
`cetal.
`
`cBrideetal.
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`
`Application Number 17870171
`Filing Date 2022-07-21
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
` Attorney Docket Number
`
`
`
`
`
`Art Unit |
`
`Examiner Name
`
`Y0090073037
`
`A=
`
`Nad
`
`o2© 2Y —_= ©
`
`Y0090093764
`
`A=
`
`P009-04-09
`
`PFEFFERet al
`
`.
`
`P0090093765
`
`Al
`
`|_ pe
`
`Y0090093796
`
`=
`
`|_
`
`P0090099638
`
`=
`
`|_
`
`P0090112312
`
`—_
`
`|-
`
`Y0090118567
`
`=
`
`P0090163864
`
`=
`
`|_ me
`
`
`Breznocketal.
`
`PO09-06-25
`
`Y0090171137
`
`Al
`
`|-
`
`P0090182188
`
`A=
`
`|-
`
`P0090234378
`
`A=
`
`P009-09-17
`
`scuderoetal.
`
`
`
`| P04000USC8
`
`
`
`onaoaon
`
`on©
`
`ow
`
`ang
`
`ooa
`
`
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`
`
`aa
`
`>ps a
`a
`Aboul-Hosnetal.
`70100210895 7PO10-08-19
`oe | BO
`70100274330 7PO10-10-28
`Burwelletal.
`fe jsfrees
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`
`
`
`Receipt date: 07/27/2022
`L7/870,172L — GAU: 3745
`
`Application Number
`17870171
`
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`|...
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`Attorney Docket Number
`
`| P04000USC8
`
`«ps aa |
`-|a a
`a me
`
`
`
`

`

`| P04000USC8
`
` Attorney Docket Number
`
`
`
`
`
`Art Unit |
`
`Examiner Name
`
`Y0100286791
`
`A=
`
`DO10-11-11
`
`oldsmith
`
`P0110004046
`
`A=
`
`P011-01-06
`
`ampbell et al.
`
`P0110004291
`
`Al
`
`P011-01-06
`
`Davis et al.
`
`P0110021865
`
`=
`
`P011-01-27
`
`
`
`Aboul-Hosnetal.
`
`P0110034874
`
`=
`
`P0110071338
`
`=
`
`P0110076439
`
`=
`
`P0110152906
`
`=
`
`P0110152907
`
`Al
`
`P0110236210
`
`A=
`
`P0110237863
`
`A=
`
`P011-09-29
`
`i
`
`
`
`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`
`Application Number 17870171
`Filing Date 2022-07-21
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`
`
`aoool
`
`ooNo
`
`Oow
`
`coa
`
`co=~
`
`
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`
`Application Number 17870171
`Filing Date 2022-07-21
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`
`
`woNo
`
`wow
`
`oOoa
`
`oO
`
`oO~]
`
`
`
`| P04000USC8
`
`Examiner Name
`
`P0110257462
`
`A=
`
`B01 1-10-20
`
`Rodefeld et al.
`
`P0110270182
`
`A=
`
`
`P011-11-03 zetal.
`
`P0110275884
`
`Al
`
`| : ° "
`
`P0120004495
`
`=
`
`P012-01-05
`
`
`
`Bolling etal.
`
`P0120029265
`
`=
`
`P0120059213
`
`=
`
`P0120142994
`
`=
`
`P0120172654
`
`=
`
`P0120172655
`
`Al
`
`P0120172656
`
`A=
`
`P0120178985
`
`A=
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`
`
`
`
`Art Unit |
`
` Attorney Docket Number
`
`
`
`

`

`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`17870171
`Application Number
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`
`
`
`
`FPRFLATRLFRR
`
`| PO4000USC8
`
` Attorney Docket Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
`Art Unit
`
`Examiner Name
`
`
`
`102
`
`103
`
`104
`
`105
`
`107
`
`P0120178986
`
`P0120184803
`
`P0120224970
`
`P0120234411
`
`P0120245404
`
`P0120265002
`
`P0130041202
`
`P0130053622
`
`P0130053623
`
`P0130085318
`
`P0130085319
`
`A=
`
`A=
`
`Al
`
`=
`
`=
`
`=
`
`=
`
`Al
`
`A=
`
`A=
`
`Nad
`
`o —_ N o7 —_= BS
`
`ampbell et al.
`
`P012-09-06
`
`Schumacheretal.
`
`P012-07-19 zetal.
`
`¢,¢, o=D9~~@
`P012-10-18 betal.
`
`P012-09-20
`
`P012-09-27
`
`P013-02-14
`
`oellner
`
`P013-02-28
`
`orbett
`
`P013-02-28
`
`vanset al.
`
`P013-04-04
`
`oellner
`
`P013-04-04
`
`vanset al.
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`17870171
`Application Number
`
`| P04000USC8
`
` Attorney Docket Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
`
`
`Art Unit |
`
`Examiner Name
`
`
`
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`
`
`112
`
`113
`
`114
`
`115
`
`117
`
`120
`
`121
`
`122
`
`P0130096364
`
`P0130103063
`
`P0130106212
`
`P0130129503
`
`P0130138205
`
`P0130204362
`
`P0130209292
`
`P0130245360
`
`P0130303969
`
`P0130303970
`
`P0130331639
`
`=FPRFLATRLFRR
`
`P013-04-18
`
`
`
`eichenbachetal.
`
`P013-08-15
`
`BAYKUTet al.
`
`A=
`
`A=
`
`Al
`
`=
`
`=
`
`=
`
`Al
`
`Al
`
`Al
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`
`Receipt date: 07/27/2022
`L7/870,172L — GAU: 3745
`
`Application Number
`17870171
`
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`|...
`
`( Not for submission under 37 CFR 1.99)
`
`
`
`
`
`
`
`Examiner Name
`
`Attorney Docket Number
`
`| P04000USC8
`
`.
`124
`125
`126
`127
`128
`129
`.
`.
`132
`133
`
`aa
`itzgeraldetal.
`P0140012065 7P014-01-09
`Schulzetal.
`P0140039465 7P014-02-06
`
`HRISTENSENetal.
`P0140088455 7P014-03-27
`oldsmith
`P0140163664 7P014-06-12
`
`Bredenbreukeretal.
`P0140255176 7P014-09-11
`Schencketal.
`P0140275725 7P014-09-18
`aa pe
`jem pe
`70140303596 7P014-10-09
`Schumacheretal.
`P0150025558 7P015-01-22
`ULFMANetal.
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`17870171
`Application Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
` Attorney Docket Number
`
`| PO4000USC8 INFORMATION DISCLOSURE
`
`
`“EH
`
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`EH
`EH
`EH
`EH
`EH
`FH
`FH
`FH
`EH
`EH
`
`Art Unit
`
`Examiner Name
`
`P015-01-29
`
`aRoseetal.
`
`P015-02-19
`
`P015-02-19
`
`Spanieret al.
`
`P015-03-19
`
`P015-03-26
`
`Spanieret al.
`
`P015-05-21
`
`oellner et al.
`
`P015-05-21
`
`P015-06-04
`
`oskoboynikovet al.
`
`P015-07-30
`
`rananoetal.
`
`P015-09-10
`
`Andersonetal.
`
`P015-10-15
`
`uller et al.
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`
`
`Receipt date: 07/27/2022 L7/870,172 ~ GAU: 3745
`Application Number
`17870171
`
`
`Filing Date
`2022-07-21
`
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENTBY APPLICANT
`
`Art Unit |
`
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`Attorney Docket Number
`
`| P04000USC8
`
`P015-12-03
`
`Schumacheret al.
`
`D016-06-30
`
`me
`
`D016-09-01
`
`ILLER etal.
`
`—_
`
`D016-09-01
`
`P0160256620
`
`D016-09-08
`
`Scheckelet al.
`
`
`
`
`
`
`
`
`
`If you wish to add additional U.S. Published Application citation information please click the Add button]Add|
`FOREIGN PATENT DOCUMENTS
`
`Pages,Columns,Lines
`
`Kind|Publication Nameof Patentee or where Relevant
`Examiner Cite|Foreign Document
`Applicantof cited
`Passages or Relevant
`Initial*
`Numbers
`Document
`:
`Figures Appear
`
`388Qc®3=2
`
`P|gESoaO‘ OooyoO
`
`1998-10-08
`
`MPELLA
`ARDIOTECHNIK
`AKTIENGESELLSCHAF
`
`UNTHER, ROLF W
`
`| 2000-10-19
`
`|
`
`=
`Bt .|Oo
`
`oO
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`
`Application Number
`17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
` Attorney Docket Number
`
`
`Examiner Name
`
` =i
`
`a
`
`GOS"08=28"""N
`
`ORPORATION
`
`OELKER, WOLFRAM,
`
`
`
` Art Unit
`|
`| P04000USC8
`
`
`
`
`
`
`
`
`
`
`
`
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`
`17870171
`Application Number
`
`2022-07-21
`Filing Date
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`Art Unit
`( Not for submission under 37 CFR 1.99)
`Examiner Name
`
` Attorney Docket Number
`
`al;S-;
`
`|.1996-02-20
`
`|B
`
`
`| PO4000USC8 S 2017-01-12
`
`
`
`NooF
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`
` a G 4
`
`
`
`ar
`
`ss
`
`ARDIOTECHNIK AG
`
`ORQIS MEDICAL
`
`
`
`
`YERIA
`PHARMA
`
`By
`
`
`
`OO
`
`
`
`
`
`L7/870,172L - GAU: 3745
`Receipt date: 07/27/2022
`17870171
`Application Number
`
` Attorney Docket Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
`Art Unit
`
`Examiner Name
`
`| PO4000USC8
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`bit)
`
`
`
`
`
`
`
`
`oe
`
`-)oO
`mocse_|
`
`
`
`
`
`
`HE PENN STATE OUNDATION
`
`
`
`
`CP
`NGA a
`NVC AK
`VY SCHAFT MBH
`
`P
`
`WTGRLON
`
`i
`
`ETY
`
`
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`
`Receipt date: 07/27/2022
`L7/870,171 - GAU: 3745
`
`Application Number
`17870171
`
`
`
`
`Filing Date
`2022-07-21
`
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`|...
`
`( Not for submission under 37 CFR 1.99)
`
`
`
`Examiner Name
`
`Attorney Docket Number
`
`| P04000USC8
`
`
`
`
`
`
`
`
`P011035927
`
`om
`
`oy
`
`
`
` | 1989-06-04 AUIMBUSMEDICAL
`
`JIACa
`
`oaN$=
`
`1
`
`_| 1999-01-21
`
`|JA-MED SYSTEMS, INC_
`
`|
`
`
`
`
`
`a
`IMBUSMEDICAL, INC
`
`=)
`|
`
`
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`L7/870,171 - GAU: 3745
`Receipt date: 07/27/2022
`
`Application Number
`17870171
`
`Filing Date
`2022-07-21
`
` INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`|...
`
`
`Examiner Name
`
`( Not for submission under 37 CFR 1.99)
`
` Attorney Docket Number
`
`
`
`
`
`
`
`| P04000USC8
`
`Ca RAL
`HERAPEUTICS,
`
`7
`
`INC
`
`bowen LIFE
`
`SYSTEMS, ING
`
`Examiner] Cite
`Initials*
`
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Include nameof the author (in CAPITAL LETTERS),title of the article (when appropriate), title of the item
`(book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
`publisher, city and/or country where published.
`
`
`
`
`
`
`
`
`
`
`
`
`
`vERKERKE, Bart et al.
`
`The PUCA Pump: A Left Ventricular Assist Device, Artificial Organs 17(5): 365-68: 1993.
`
`
`
`WMERKERKE, CJ et al., Numerical Simulation of the PUCA Pump, A Left Ventricular Assist Device, Abstracts of the
`f
`i
`;
`5
`KIXth ESAO Congress, The International JournalofArtificial Organs 15(9): 543; 1992
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`|
`
`|
`
`:
`
`

`

`L7/870,171 - GAU: 3745
`Receipt date: 07/27/2022
`
`Application Number
`17870171
`
`
`Filing Date 2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`|...
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
` Attorney Docket Number
`
`
`
`
`
`
`
`| P04000USC8
`
`EXAMINER SIGNATURE
`
`*EXAMINER:Initial if reference considered, whetheror not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP $01.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). > For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial numberof the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. * Applicantis to place a check mark here if
`English language translation is attached.
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`L7/870,171 - GAU: 3745
`Receipt date: 07/27/2022
`
`Application Number
`17870171
`
`Filing Date
`2022-07-21
`
` INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`|...
`
` Attorney Docket Number
`
`
`Examiner Name
`
`| P04000USC8
`
`
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection{s):
`
`CERTIFICATION STATEMENT
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three monthsprior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`[-]
`
`> See attached certification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`A certification statement is not submitted herewith.
`
`SIGNATURE
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`Signature
`
` Name/Print
`
`2022-07-27
`
`1,785
`
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public whichis to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`

`

`Receipt date: 07/27/2022
`
`L7/870,172 ~ GAU: 3745
`
`Privacy Act Statement
`
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that:
`(1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonmentof the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Departmentof Justice to determine whether the Freedom ofInformation Act requires disclosure of these record s.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence toa
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`requestinvolving an individual, to whom the record pertains, when the individual has requested assistance from the
`Memberwith respect to the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSAaspart of that agency's responsibility to
`recommend improvements in records management practices and programs, underauthority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant(i.e., GSA or Commerce)directive. Such disclosure shall not be used to make
`determinations about individuals.
`
` The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`
`
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record wasfiled in
`an application which became abandonedor in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency,if the USPTO becomes aware ofa violation or potential violation of law or regulation.
`
`EFS Web 2.1.18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/A.M./
`
`